Cochlear | COH - 销售收入

股票价格
185.00
每天变化
-0.83 -0.45%
每月一次
-26.05%
每年
-32.82%
Q1 预测
191.63


金融业
股票价格
AUD
资产
AUD 2.79B
现金及等价物
AUD 275.7M
销售成本
AUD 319.2M
流动资产
AUD 1.37B
流动负债
AUD 558.9M
债务
AUD 235.7M
股息收益率
1.17
EBIT
AUD 261.1M
EBITDA
AUD 306.4M
员工
5.5K
EPS每股收益
AUD 3.13
股本和储备
AUD 1.94B
销售毛利
AUD 856.8M
债务利息支出
AUD 6.3M
利息收入
AUD 7.4M
贷款资金
AUD 200M
市值
AUD 12.1B
净收入
AUD 161.5M
营业费用
AUD 914.9M
营业利润
AUD 261.1M
普通股股本
AUD 65.4M
PE价格收益
AUD 43.67
税前利润
AUD 121.1M
销售收入
AUD 1.18B
销售和管理费用
AUD 449.4M
股票
AUD 499.4M
贸易债权人
AUD 281.3M
应收帐款人
AUD 568.4M


销售 更改 日
Ansell USD 1.03B 192.2M 2025-12
Avita Medical AUD 17.61M 805K 2025-12
Cochlear AUD 1.18B 590.35M 2025-12
CSL USD 8.33B 4.79B 2025-12
Fisher Paykel Healthcare NZD 1.1B 21.3M 2025-12
Healius AUD 688.1M 245.8M 2025-12
Integral Diagnostics AUD 238.44M 7.19M 2024-06
Mayne Pharma AUD 212.07M 17.03M 2025-12
Mesoblast USD 51.34M 38.14M 2025-12
Monash IVF AUD 137.86M 72.09M 2025-12
Nanosonics AUD 102.23M 2.8M 2025-12
Polynovo AUD 70.33M 35.75M 2025-12
Ramsay Health Care AUD 9.34B 82.2M 2025-12
Regis Healthcare AUD 667.75M 48.69M 2025-12
ResMed USD 1.42B 87.23M 2025-12
Sigma Healthcare AUD 1.68B 188.65M 2024-12
Somnomed AUD 45.11M 1.46M 2023-12
Sonic Healthcare AUD 5.45B 470M 2025-12
Telix Pharmaceuticals AUD 413.44M 103.71M 2025-12